Loading clinical trials...
Loading clinical trials...
To assess potential benefits associated with both intermittent (use for 3 weeks, remove for 1 week, as defined in the package insert) and continuous (use for 4 weeks, then replace) CVR use among women...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Washington
Collaborators
NCT07394777 · Bacterial Vaginosis (BV)
NCT01829204 · Vulvodynia, Mycoses, and more
NCT04046900 · Recurrent Bacterial Vaginosis
NCT04771728 · Bacterial Vaginosis
NCT06472765 · Bacterial Vaginosis, Candidiasis, and more
UW Virology Research Clinic
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions